Diovan HCT Articles
Mylan debuts first generic Diovan HCT and Antivert copy in USA
23 September 2012
Actavis debuts generic Diovan in major European markets
20 November 2011
Novartis' 1st-qtr 2009 results boosted by new products
24 April 2009
Four Novartis drugs and B-MS
9 March 2009
FDA OKs higher dose of Novartis' Diovan
8 May 2006
Beaufour Ipsen to sell valsartan in France
19 May 2003
FDA Approvals In Brief
11 March 1998
Showing 1-8 of 8 articles
- 1
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Italy's pharma market slump set to continue, warns GlobalData
